PSMA/PSA ratio evaluated by immunohistochemistry may improve diagnosis of prostate cancer

Journal of Immunoassay and Immunochemistry

Volumn 35, Issue 1, 2014, Pages 48-59

  Jemaa, Awatef Ben ^a   Bouraoui, Yosra ^a   Sallami, Sataa ^b   Banasr, Ahmed ^c   Nouira, Yassine ^b   Oueslati, Ridha ^a  

^a UNIVERSITY OF CARTHAGE   (Tunisia)

^b LA RABTA HOSPITAL   (Tunisia)

^c CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

angiogenesis; diagnosis; prostate cancer (PC); prostate specific antigen (PSA); prostate specific membrane antigen (PSMA); ratio

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; PROSTATE SPECIFIC MEMBRANE ANTIGEN;

ADULT; AGED; ANGIOGENESIS; ANTIGEN EXPRESSION; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER PROGNOSIS; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTIGENS, SURFACE; CASE-CONTROL STUDIES; DATA INTERPRETATION, STATISTICAL; GENE EXPRESSION; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 84885011838     PISSN: 15321819     EISSN: 15324230     Source Type: Journal    
DOI: 10.1080/15321819.2013.792830     Document Type: Article

References (26)

1. Jemal, A.; Bray, F.; Center, M. M.; Ferlay, J.; Ward, E.; Forman, D. Global Cancer Statistics. CA Cancer J. Clin. 2011, 61(2), 69-90
2. Lilja, H.; Ulmert, D.; Vickers, A. J. Prostate-Specific Antigen and Prostate Cancer: Prediction, Detection and Monitoring. Nat Rev. Cancer 2008, 8(4), 268-278
3. Williams, S. A.; Singh, P.; Isaacs, J. T.; Denmeade, S. R. Does PSA Play a role as a Promoting Agent during the Initiation and=or Progression of Prostate Cancer Prostate 2007, 67(3), 312-329
4. Roscigno, M.; Scattoni, V.; Bertini, R.; Pasta, A.; Montorsi, F.; Rigatti, P. Diagnosis of Prostate Cancer. State of the Art. Minerva Urol. Nefrol. 2004, 56, 123-145
5. Stephan, C.; Jung, K.; Lein, M.; Sinha, P.; Schnorr, D.; Loening, S. A. Molecular Forms of Prostate-Specific Antigen and Human Kallikrein 2 as Promising Tools for Early Diagnosis of Prostate Cancer. Cancer Epidemiol. Biomark. Prev. 2000, 9(11), 1133-1147
6. Bouraoui, Y.; Ben, Rais, N.; Elouni, Z.; Mezigh, C.; Machghoul, S.; Oueslati, R. Evolution?s Molecular Forms of Prostate-Specific-Antigen in Serological Groups of Patients with Prostatic Pathologies. Immunobiology 2006, 21, 286-291
7. Madu, C. O.; Lu, Y. Novel Diagnostic Biomarkers for Prostate Cancer. J. Cancer 2010, 6(1), 150-177
8. Denmeade, S. R.; Mhaka, A. M.; Rosen, D. M.; Brennen, W. N.; Dalrymple, S.; Dach, I.; Olesen, C.; Gurel, B.; Demarzo, A. M.; Wilding, G.; Carducci, M. A.; Dionne, C. A.; Møller, J. V.; Nissen, P.; Christensen, S. B.; Isaacs, J. T. Engineering a prostate-Specific Membrane Antigen-Activated Tumor Endothelial Cell Prodrug for Cancer Therapy. Sci. Transl, Med. 2012, 4(140), 140ra86
9. Chang, S. S. Overview of Prostate-Specific Membrane Antigen. Rev. Urol. 6 Suppl. 2004, 10, S13-S18
10. Pinto, J. T.; Suffoletto, B. P.; Berzin, T. M.; Qiao, C. H.; Lin, S.; Tong, W. P.; May, F.; Mukherjee, B.; Heston, W. D. Prostate-Specific Membrane Antigen: A Novel Folate Hydrolase in Human Prostatic Carcinoma Cells. Clin. Cancer Res. 1996, 2, 1445-1451
11. Lapidus, R. G.; Tiffany, C. W.; Isaacs, J. T.; Slusher BS: Prostate-Specific Membrane Antigen (PSMA) Enzyme Activity Is Elevated In Prostate Cancer Cells. Prostate 2000, 45, 350-354
12. Anilkumar, G.; Rajasekaran, S. A.; Wang, S.; Hankinson, O.; Bander, N. H.; Rajasekaran, A. K. Prostate-specific Membrane Antigen Association with Filamin A Modulates its Internalization and NAALADase Activity. Cancer Res. 2003, 63, 2645-2648
13. Perner, S.; Hofer, M. D.; Kim, R.; Shah, R. B.; Li, H.; Moller, P.; Hautmann, R. E.; Gschwendt, J. E.; Kuefer, R.; Rubin, M. A. Prostate-Specific Membrane Antigen Expression as a Predictor of Prostate Cancer Progression. Hum Pathol. 2007, 38, 696-701
14. Rajasekaran, A. K.; Anilkumar, G.; Christiansen, J. J. Is Prostate-Specific Membrane Antigen a Multifunctional Protein Amer. J. Physiol. Cell Physiol. 2005, 288, C975-C981
15. Grant, C. L.; Caromile, L. A.; Durrani, K.; Rahman, M. M.; Claffey, K. P.; Fong, G. H.; Shapiro, L. H. Prostate Specific Membrane Antigen (PSMA) Regulates Angiogenesis Independently of VEGF during Ocular Neovascularization. PLoS One. 2012, 7(7), e41285
16. Horoszewicz, J. S.; Kawinski, E.; Murphy, G. P. Monoclonal Antibodies to a New Antigenic Marker in Epithelial Cells and Serum of Prostatic Cancer Patients. Anticancer Res. 1987, 7, 927-936
17. Stamey, T. A. Preoperative Serum Prostate-Specific Antigen (PSA) below 10 microg=l Predicts Neither the Presence of Prostate Cancer nor the Rate of Postoperative PSA Failure. Clin Chem. 2001, 47, 631-634
18. Denmeade, S. R.; Sokoll, L. J.; Dalrymple, S.; Rosen, D. M.; Gady, A. M.; Bruzek, D.; Ricklis, R. M.; Isaacs, J. T. Dissociation between Androgen Responsiveness for Malignant Growth vs Expression of Prostate Specific Differentiation Markers PSA, hK2, and PSMA in Human Prostate Cancer Models. Prostate 2003, 54, 249-257
19. Kawakami, M.; Nakayama, J. Enhanced Expression of Prostate-Specific Membrane Antigen Gene in Prostate Cancer as Revealed by in situ Hybridization. Cancer Res. 1997, 57(12), 2321-2324
20. Bouraoui, Y.; Ricote, M.; Garća-Tun?ón, I.; Rodriguez-Berriguete, G.; Touffehi, M.; Rais, N. B.; Fraile, B.; Paniagua, R.; Oueslati, R.; Royuela, M. Pro-inflammatory Cytokines and Prostate-Specific Antigen in Hyperplasia and Human Prostate Cancer. Cancer Detect Prev. 2008, 32(1), 23-32
21. Mechergui, Y. B.; Ben Jemaa, A.; Mezigh, C.; Fraile, B.; Ben Rais, N.; Paniagua, R.; Royuela, M.; Oueslati, R. The Profile of Prostate Epithelial Cytokines and its Impact on Sera Prostate Specific Antigen Levels. Inflammation 2009, 32(3), 202-210
22. Conway, R. E.; Petrovic, N.; Li, Z.; Heston, W.; Wu, D.; Shapiro, L. H. Prostate-specific Membrane Antigen Regulates Angiogenesis by Modulating Integrin Signal Transduction. Mol Cell Biol. 2006, 26, 5310-5324
23. Colombatti, M.; Grasso, S.; Porzia, A.; Fracasso, G.; Scupoli, M. T.; Cingarlini, S.; Poffe, O.; Naim, H. Y.; Heine, M.; Tridente, G.; Mainiero, F.; Ramarli, D. The Prostate Specific Membrane Antigen Regulates the Expression of IL-6 and CCL5 in Prostate Tumour Cells by Activating the MAPK Pathways. PLoS One 2009, 4(2), e4608
24. Aihara, M.; Lebovitz, R. M.; Wheeler, T. M.; Kinner, B. M.; Ohori, M.; Scardino, P. T. Prostate Specific Antigen and Gleason Grade: An Immunohistochemical Study of Prostate Cancer. J. Urol. 1994, 151(6), 1558-1564
25. Fortier, A. H.; Holaday, J. W.; Liang, H.; Dey, C.; Grella, D. K.; Holland-Linn, J.; Vu, H.; Plum, S. M.; Nelson BJ. Recombinant Prostate Specific Antigen Inhibits Angiogenesis in vitro and in vivo. Prostate 2003, 56(3), 212-219
26. Heidtmann, H. H.; Nettelbeck, D. M.; Mingels, A.; Jager, R.; Welker, H. G.; Kontermann, R. E. Generation of Angiostatin-like Fragments from Plasminogen by Prostate-specific Antigen. Br. J. Cancer. 1999, 81, 1269-1273